--- title: Here’s the Testing Strategy We Need to Safely Reopen America description: Former FDA commissioner Scott Gottlieb on a three layered testing regime that will help protect Americans and manage the risk of COVID-19 canonical: https://time.com/5836206/scott-gottlieb-covid-19-testing-systems/ author: TIME article:opinion: true article:content_tier: free article:published_time: 2020-05-13T17:51:04.000Z article:modified_time: 2026-08-04T07:52:07.391Z article:section: Ideas og:title: Former FDA Head: Here’s the Testing Strategy We Need to Safely Reopen America og:description: Former FDA commissioner Scott Gottlieb on a three layered testing regime that will help protect Americans and manage the risk of COVID-19 og:url: https://time.com/5836206/scott-gottlieb-covid-19-testing-systems/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt765f326fa37cc60e/698a0dff97cdff75d76bab8e/covid-19-testing.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 2400 og:image:height: 1350 og:image:alt: CORONAVIRUS TESTING og:type: article twitter:card: summary_large_image twitter:title: Former FDA Head: Here’s the Testing Strategy We Need to Safely Reopen America twitter:description: Former FDA commissioner Scott Gottlieb on a three layered testing regime that will help protect Americans and manage the risk of COVID-19 twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt765f326fa37cc60e/698a0dff97cdff75d76bab8e/covid-19-testing.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # Former FDA Commissioner: Here’s the Testing Strategy We Need to Safely Reopen America > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=343ec7e8-ba3e-4617-bfa3-b161a73a3458&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Daily | | Worth Your Time | A weekly guide to what to watch, read, and more | Tuesday and Saturday (2x per week) | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Monday to Saturday (3x per week) | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=343ec7e8-ba3e-4617-bfa3-b161a73a3458&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=343ec7e8-ba3e-4617-bfa3-b161a73a3458&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (daily health), Worth Your Time (culture, twice weekly), D.C. Brief (Washington politics, three times a week), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ## Video: How 'Broad, Ubiquitous Testing' Can Help Restart the U.S. Economy [Watch (HLS stream): How 'Broad, Ubiquitous Testing' Can Help Restart the U.S. Economy](https://cdn.jwplayer.com/manifests/8RJ2Cjhj.m3u8) (2:58)  _Published 2020-04-23. TIME hosts the first-ever TIME 100 Talks_  by [Dr. Scott Gottlieb](https://time.com/author/dr-scott-gottlieb/)  ## Dr. Scott Gottlieb May 13, 2020 5:51 PM UTC  A healthcare worker conducts a COVID-19 test at a drive-thru testing facility at George Washington University on Tuesday, May 5, 2020. A healthcare worker conducts a COVID-19 test at a drive-thru testing facility at George Washington University on Tuesday, May 5, 2020. Caroline Brehman—CQ-Roll Call/Getty Images  by [Dr. Scott Gottlieb](https://time.com/author/dr-scott-gottlieb/)  ## Dr. Scott Gottlieb May 13, 2020 5:51 PM UTC Everyone wants to know when we’ll be safe from [COVID-19](https://time.com/tag/covid-19/). The answer is we’re probably in for a long fight. We’ll face a [persistent risk](https://time.com/5829387/coronavirus-reopening-science/), maybe until we get a vaccine, or even after. But that risk can be managed, and reduced, if we focus on helping those at the greatest threat of getting the disease. Reliable tests for the presence of antibodies (which tell who has had the disease) will be very important. But we also need tests that reveal who is carrying the virus to find the illness in our communities and get people access to care before individual cases turn into outbreaks and outbreaks into a new epidemic. We have the technology and public-health tools to achieve these goals, and new capabilities are being quickly developed to scale faster testing. A critical element going forward is the ability to bring accessible, dependable and affordable testing to people who have symptoms or are at risk of contracting the disease. That doesn’t mean we need to screen everyone all the time. But for those who are symptomatic or were exposed to the illness—or for those people who work in professions or live in communities where there’s a higher chance for spread—we need to make sure that testing is available. We’ve largely relied on a technology called polymerase chain reaction (PCR), where swabs are used to collect samples, which are then scoured for the virus’s genetic material. This RNA is then amplified and analyzed to reveal the presence of active virus. But the whole process takes time, and results may not be available for at least a day. The supply chain to support these PCR platforms is also stretched, and our network of labs is close to its limit. We’re conducting around 300,000 tests a day. Given [constraints on logistics and supply chains](https://time.com/5828843/trump-coronavirus-testing-giroir/), the upper limit is probably 500,000. New technologies are becoming available that will expand testing so that it will be accessible whether you’re a large employer, a patient in a community setting or a college student returning to campus. The key will be matching the right testing solution to the right medical need. The first layer of testing is frontline solutions that offer routine screening right in a doctor’s office. These include machines like the [Abbott ID NOW test](https://time.com/5812664/5-minute-coronavirus-test/) that the White House is currently using and that can give a result in five to 13 minutes. The Cepheid GeneXpert is a highly accurate testing system that generates results at the point of care in 30 to 45 minutes. This month, a [rapid test by Quidel](https://www.nbcnews.com/health/health-news/new-coronavirus-test-imperfect-step-toward-mass-screening-n1204741) was authorized under emergency-use authorization by the FDA. It screens for antigens that the virus emits and gives a result in minutes. These tests are relatively cheap, easy and fast. Their limitation is that they’re highly specific, but (with the exception of the GeneXpert) they’re not uniformly sensitive. That means if they say you have COVID-19, you almost certainly do. But sometimes they’ll say you aren’t infected when you really are. In the hands of a health provider, these point-of-care tests can help rapidly diagnose most patients. For those who get a negative test but have suggestive symptoms, the doctor can send off the PCR-based test as confirmation and wait for the result. The next layer of testing is the PCR machines that offer more reliable results but take time to run. They’ll continue to have an important role when accuracy counts. But to enable widespread screening of mostly healthy people (think of a workplace that wants to screen its entire workforce on a regular basis) we need a third layer of tools that allow quick and accurate screening of large populations. For these tasks, you want machines that can screen many people with a high degree of precision, even if they don’t have any symptoms. Consider a model where employees would spit in tubes and then the samples would be pooled together in groups of 50 or even 100 and tested overnight to see if anyone has coronavirus. If a pooled sample gets a hit, the workers could be individually screened using PCR. I work with technologies and services that can be used for this kind of screening at the workplace. These kinds of platforms are already available, and some large employers are going to be using them to implement broad screening of their workforces. Keeping people safe requires tests that are easy, affordable and available. We need to make sure that people who work or live in places that put them at higher risk have access to these opportunities. ```json [{"@context":"https://schema.org","@type":"OpinionNewsArticle","@id":"https://time.com/5836206/scott-gottlieb-covid-19-testing-systems/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/5836206/scott-gottlieb-covid-19-testing-systems/"},"headline":"Former FDA Commissioner: Here’s the Testing Strategy We Need to Safely Reopen America","datePublished":"2020-05-13T17:51:04.000Z","dateModified":"2026-08-04T07:52:07.391Z","description":"Former FDA commissioner Scott Gottlieb on a three layered testing regime that will help protect Americans and manage the risk of COVID-19","url":"https://time.com/5836206/scott-gottlieb-covid-19-testing-systems/","keywords":["COVID-19"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt765f326fa37cc60e/698a0dff97cdff75d76bab8e/covid-19-testing.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Dr. Scott Gottlieb","jobTitle":null,"url":"https://time.com/author/dr-scott-gottlieb/"}],"articleSection":"Ideas","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt765f326fa37cc60e/698a0dff97cdff75d76bab8e/covid-19-testing.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"CORONAVIRUS TESTING","caption":"A healthcare worker conducts a COVID-19 test at a drive-thru testing facility at George Washington University on Tuesday, May 5, 2020.","creditText":"Caroline Brehman—CQ-Roll Call/Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/ideas/","name":"Ideas"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/covid-19/","name":"COVID-19"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/5836206/scott-gottlieb-covid-19-testing-systems/","name":"Former FDA Commissioner: Here’s the Testing Strategy We Need to Safely Reopen America"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"How 'Broad, Ubiquitous Testing' Can Help Restart the U.S. Economy","description":"TIME hosts the first-ever TIME 100 Talks","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/8RJ2Cjhj/poster.jpg?width=720","uploadDate":"2020-04-23T19:36:01.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/8RJ2Cjhj.m3u8","embedUrl":"https://time.com/5836206/scott-gottlieb-covid-19-testing-systems/","duration":"PT2M58S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/5836206/scott-gottlieb-covid-19-testing-systems/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```